Transform how you find answers with
QIAGEN Clinical Insight
QCI automatically incorporates actionability criteria supporting tier classifications of the AMP/ASCO/CAP and ACMG/AMP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
The QIAGEN Knowledge Base stands as an interconnected and interdependent network of structured data built by MD and PhD certified content curation specialists. With one click, you receive information on the variant’s characteristics, active clinical trial registries, and available drug therapies.
Implement a full workflow for variant calling through pre-configured and expandable NGS secondary data analysis pipelines that take you from FASTQ to VCF faster. QCI Analyze Universal is the companion product to QCI Interpret that allows you to confidently identify variants from your NGS tests.
Offering the highest level of interpretation transparency currently available in the market, QCI Interpret displays every piece of supporting evidence included in the interpretation process.
The software is connected to the QIAGEN Knowledge Base, the industry’s largest, most-up-to-date clinical database with over 16 million biological findings.
Pulling data from clinical trials, case studies, peer-reviewed literature, drug labels, external databases, professional guidelines, and the direct experience of interpreting over 1 MILLION human samples, the QIAGEN Knowledge Base is unrivalled in clinical breadth and depth.